{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:24:14Z","timestamp":1777364654549,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1186\/s12920-018-0419-x","type":"journal-article","created":{"date-parts":[[2018,11,16]],"date-time":"2018-11-16T15:41:39Z","timestamp":1542382899000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Toward the precision breast cancer survival prediction utilizing combined whole genome-wide expression and somatic mutation analysis"],"prefix":"10.1186","volume":"11","author":[{"given":"Yifan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack Y","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renchu","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Qu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,20]]},"reference":[{"key":"419_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21332","volume":"66","author":"RL Siegel","year":"2016","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7\u201330.","journal-title":"CA Cancer J Clin"},{"key":"419_CR2","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1038\/s41598-017-02937-0","volume":"7","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, et al. \u03b2-Lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci Rep. 2017;7:2681.","journal-title":"Sci Rep"},{"key":"419_CR3","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nrc1670","volume":"5","author":"B Weigelt","year":"2005","unstructured":"Weigelt B, Peterse JL, van\u2019t VLJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5:591\u2013602.","journal-title":"Nat Rev Cancer"},{"key":"419_CR4","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365:1687\u201317.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"419_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejpb.2008.01.015","volume":"69","author":"B Liu","year":"2008","unstructured":"Liu B, Yang M, Li R, Ding Y, Qian X, Yu L, et al. The antitumor effect of novel docetaxel-loaded thermosensitive micelles. Eur J Pharm Biopharm. 2008;69:527\u201334.","journal-title":"Eur J Pharm Biopharm"},{"key":"419_CR6","first-page":"8500","volume":"8","author":"J Li","year":"2015","unstructured":"Li J, Chen Z, Su K, Zeng J. Clinicopathological classification and traditional prognostic indicators of breast cancer. Int J Clin Exp Pathol. 2015;8:8500\u20135.","journal-title":"Int J Clin Exp Pathol"},{"key":"419_CR7","doi-asserted-by":"publisher","first-page":"45554","DOI":"10.1038\/srep45554","volume":"7","author":"G Gong","year":"2017","unstructured":"Gong G, Kwon MJ, Han J, Lee HJ, Lee SK, Lee JE, et al. A new molecular prognostic score for predicting the risk of distant metastasis in patients with HR+\/HER2\u2212 early breast cancer. Sci Rep. 2017;7:45554.","journal-title":"Sci Rep"},{"key":"419_CR8","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/35000501","volume":"403","author":"AA Alizadeh","year":"2000","unstructured":"Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503\u201311.","journal-title":"Nature"},{"key":"419_CR9","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T S\u00f8rlie","year":"2001","unstructured":"S\u00f8rlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci"},{"key":"419_CR10","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"van de Vijver MJ, He YD, van \u2018t Veer LJ, Dai H, Hart AAM, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast Cancer. N Engl J Med. 2002;347:1999\u20132009.","journal-title":"N Engl J Med"},{"key":"419_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11453","volume":"490","author":"TCGA Network","year":"2012","unstructured":"Network TCGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"419_CR12","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1371\/journal.pbio.0020108","volume":"2","author":"E Bair","year":"2004","unstructured":"Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol. 2004;2:e108.","journal-title":"PLoS Biol"},{"key":"419_CR13","doi-asserted-by":"publisher","first-page":"16553","DOI":"10.1038\/srep16553","volume":"5","author":"J Sun","year":"2015","unstructured":"Sun J, Chen X, Wang Z, Guo M, Shi H, Wang X, et al. A potential prognostic long non-coding RNA signature to predict metastasis-free survival of breast cancer patients. Sci Rep. 2015;5:16553.","journal-title":"Sci Rep"},{"key":"419_CR14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1534\/genetics.116.189191","volume":"205","author":"X Zhang","year":"2017","unstructured":"Zhang X, Li Y, Akinyemiju T, Ojesina AI, Buckhaults P, Liu N, et al. Pathway-structured predictive model for Cancer survival prediction: a two-stage approach. Genetics. 2017;205:89\u2013100.","journal-title":"Genetics"},{"key":"419_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534:47\u201354.","journal-title":"Nature"},{"key":"419_CR16","doi-asserted-by":"crossref","unstructured":"Zhong Q, Peng H-L, Zhao X, Zhang L, Hwang W-T. Effects of BRCA1- and BRCA2-related mutations on ovarian and breast cancer survival: a meta-analysis. Clin Cancer res. 2014;:clincanres1816.2014.","DOI":"10.1158\/1078-0432.CCR-14-1816"},{"key":"419_CR17","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/cas.13182","volume":"108","author":"W Tonghui","year":"2017","unstructured":"Tonghui W, Ye X, Shuyan S, Hua Y, Tao O, Li J, et al. HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers. Cancer Sci. 2017;108:671\u20137.","journal-title":"Cancer Sci"},{"key":"419_CR18","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/j.celrep.2016.10.031","volume":"17","author":"F Pucci","year":"2016","unstructured":"Pucci F, Rickelt S, Newton AP, Garris C, Nunes E, Evavold C, et al. PF4 promotes platelet production and lung Cancer growth. Cell Rep. 2016;17:1764\u201372.","journal-title":"Cell Rep"},{"key":"419_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bbrc.2014.11.064","volume":"456","author":"Y-F Zhao","year":"2015","unstructured":"Zhao Y-F, Zhao J-Y, Yue H, Hu K-S, Shen H, Guo Z-G, et al. FOXD1 promotes breast cancer proliferation and chemotherapeutic drug resistance by targeting p27. Biochem Biophys Res Commun. 2015;456:232\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"419_CR20","doi-asserted-by":"publisher","first-page":"5991","DOI":"10.1007\/s13277-015-4437-4","volume":"37","author":"H Song","year":"2016","unstructured":"Song H, He W, Huang X, Zhang H, Huang T. High expression of FOXR2 in breast cancer correlates with poor prognosis. Tumor Biol. 2016;37:5991\u20137.","journal-title":"Tumor Biol"},{"key":"419_CR21","doi-asserted-by":"publisher","first-page":"P44","DOI":"10.1186\/1471-2164-15-S2-P44","volume":"15","author":"S Mathew","year":"2014","unstructured":"Mathew S, Merdad A, Al-Maghrabi J, Dallol A. Identification of frequent MTNR1B methylation in breast cancer following the application of high-throughput methylome analysis. BMC Genomics. 2014;15:P44.","journal-title":"BMC Genomics"},{"key":"419_CR22","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1016\/S0140-6736(11)61539-0","volume":"378","author":"JS Reis-Filho","year":"2011","unstructured":"Reis-Filho JS, Pusztai L. Gene expression profiling in breast cancer: classification, prognostication, and prediction. Lancet. 2011;378:1812\u201323.","journal-title":"Lancet"},{"key":"419_CR23","doi-asserted-by":"publisher","first-page":"13386","DOI":"10.1074\/jbc.M115.655175","volume":"290","author":"SA Fakhraldeen","year":"2015","unstructured":"Fakhraldeen SA, Clark RJ, Roopra A, Chin EN, Huang W, Castorino J, et al. Two isoforms of the RNA binding protein, coding region determinant-binding protein (CRD-BP\/IGF2BP1), are expressed in breast epithelium and support Clonogenic growth of breast tumor cells. J Biol Chem. 2015;290:13386\u2013400.","journal-title":"J Biol Chem"},{"key":"419_CR24","unstructured":"Syndecan-1 in Breast Cancer Stroma Fibroblasts Regulates Extracellular Matrix Fiber Organization and Carcinoma Cell Motility - Am J Pathol http:\/\/ajp.amjpathol.org\/article\/S0002-9440(10)00086-6\/abstract . Accessed 9 Apr 2018."},{"key":"419_CR25","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1101\/gr.772403","volume":"13","author":"PD Thomas","year":"2003","unstructured":"Thomas PD, Campbell MJ, Kejariwal A, Mi H, Karlak B, Daverman R, et al. PANTHER: a library of protein families and subfamilies indexed by function. Genome Res. 2003;13:2129\u201341.","journal-title":"Genome Res"},{"key":"419_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0960-0760(02)00254-6","volume":"83","author":"L Liao","year":"2002","unstructured":"Liao L, Kuang S-Q, Yuan Y, Gonzalez SM, O\u2019Malley BW, Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3\/AIB1. J Steroid Biochem Mol Biol. 2002;83:3\u201314.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"419_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1136\/gut.42.5.673","volume":"42","author":"JR Jass","year":"1998","unstructured":"Jass JR, Do K-A, Simms LA, Iino H, Wynter C, Pillay SP, et al. Morphology of sporadic colorectal cancer with DNA replication errors. Gut. 1998;42:673\u20139.","journal-title":"Gut"},{"key":"419_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10555-008-9166-3","volume":"28","author":"A Hall","year":"2009","unstructured":"Hall A. The cytoskeleton and cancer. Cancer Metastasis Rev. 2009;28:5\u201314.","journal-title":"Cancer Metastasis Rev"},{"key":"419_CR29","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486:346\u201352.","journal-title":"Nature"},{"key":"419_CR30","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4:44\u201357.","journal-title":"Nat Protoc"},{"key":"419_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"DW Huang","year":"2009","unstructured":"Huang DW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009;37:1\u201313.","journal-title":"Nucleic Acids Res"},{"key":"419_CR32","doi-asserted-by":"publisher","first-page":"6994","DOI":"10.1073\/pnas.0912708107","volume":"107","author":"ML Gatza","year":"2010","unstructured":"Gatza ML, Lucas JE, Barry WT, Kim JW, Wang Q, Crawford MD, et al. A pathway-based classification of human breast cancer. Proc Natl Acad Sci. 2010;107:6994\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"419_CR33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2164-15-244","volume":"15","author":"H Xu","year":"2014","unstructured":"Xu H, DiCarlo J, Satya RV, Peng Q, Wang Y. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics. 2014;15:244.","journal-title":"BMC Genomics"},{"key":"419_CR34","doi-asserted-by":"publisher","first-page":"e0151664","DOI":"10.1371\/journal.pone.0151664","volume":"11","author":"AB Kr\u00f8ig\u00e5rd","year":"2016","unstructured":"Kr\u00f8ig\u00e5rd AB, Thomassen M, L\u00e6nkholm A-V, Kruse TA, Larsen MJ. Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data. PLoS One. 2016;11:e0151664.","journal-title":"PLoS One"},{"key":"419_CR35","doi-asserted-by":"crossref","unstructured":"Mitchell M. An introduction to genetic algorithms.\u00a0Cambridge: MIT Press; 1998.","DOI":"10.7551\/mitpress\/3927.001.0001"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12920-018-0419-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-018-0419-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,15]],"date-time":"2020-11-15T10:55:47Z","timestamp":1605437747000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedgenomics.biomedcentral.com\/articles\/10.1186\/s12920-018-0419-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":35,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["419"],"URL":"https:\/\/doi.org\/10.1186\/s12920-018-0419-x","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"20 November 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"104"}}